Sleeping Bruxism Treatment Market - Top Companies and Manufacturers

  • Report ID: 6939
  • Published Date: Jan 07, 2025
  • Report Format: PDF, PPT

Companies Dominating the Sleeping Bruxism Treatment Landscape

    Key companies in the sleeping bruxism treatment market are innovating by developing advanced solutions like custom-made mouthguards, biofeedback devices, and wearable technologies. These innovations enable more effective management by offering personalized treatments, real-time monitoring, and non-invasive options. Companies are also enhancing diagnostic tools, such as portable sleep monitors, to facilitate early detection, driving growth by improving treatment outcomes and patient adherence. These companies are:

    • Randmark Dental Products, LLC.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Ivoclar Vivadent AG
    • Ipsen S.A.
    • Merz Pharma GmbH & Co. KGaA
    • Carestream Dental
    • Akervall Technologies Inc
    • Planmeca Oy
    • S4S Limited
    • Patterson Dental Supply, Inc
    • Henry Schein, Inc
    • Pfizer, Inc
    • GC International AG
    • ALIGNERCO

Browse Key Market Insights with Data Illustration:

In the News

  • In July 2024, ALIGNERCO launched a series of new mouthguards, night guards, and retainers. The custom hybrid night guard was designed to capture consumers with a limited budget, providing comfortable and effective protection against grinding, clenching, and bruxism. 
  • In November 2021, the FDA approved SprintRay’s NightGuard Flex resin, a Class II device for bruxism treatment.

Author Credits:  Radhika Pawar


  • Report ID: 6939
  • Published Date: Jan 07, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the sleeping bruxism treatment market was over USD 1.30 billion.

The market size for the sleeping bruxism treatment market is projected to reach USD 2.87 billion by the end of 2037 expanding at a CAGR of 6.8% during the forecast period i.e., between 2025-2037.

The major players in the market are Carestream Dental, Akervall Technologies Inc., Planmeca Oy, and others.

In terms of product type segment, the NTI-tss and splints segment is anticipated to garner the largest market share by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 39.5% by the end of 2037 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample